rss twitter facebook


RA News

Withdrawal of TNF Inhibitors Fails in Most RA Patients

TNF inhibitors are biologic drugs that are commonly used in the treatment of rheumatoid arthritis (RA) and certain other autoimmune conditions. These drugs include Enbrel® (etanercept), Remicade® (infliximab), Humira® (adalimumab), Cimzia® (certolizumab), and Simponi® (golimumab). Many patients wonder how long they need to remain on therapy to control symptoms of…

Orencia Approved for Use in Psoriatic Arthritis

The U.S. Food and Drug Administration (FDA) has approved ORENCIA (abatacept) for the treatment of adults with active Psoriatic Arthritis (PsA). Approval is for both intravenous and subcutaneous (SC) injection formulations. Psoriatic arthritis is a condition that stems from psoriasis, an autoimmune disease in which the body’s immune system attacks…

Rituxan May Improve Rheumatoid Lung Disease

A single-center clinical trial with 10-year follow-up study of rheumatoid arthritis (RA) shows that treatment with Rituxan® (rituximab) in patients with RA-related interstitial lung disease (RA-ILD) may halt disease progression in the lungs. Rheumatoid arthritis is a chronic inflammatory disease that causes pain, stiffness, swelling, and limitation in the motion…

Managing Inflammatory Arthritis From Checkpoint Inhibitors

Inflammatory arthritis is a newly recognized side effect associated with immune checkpoint blockade, an increasingly used treatment for a number of cancers. According to Johns Hopkins doctors who submitted the report, immune checkpoint inhibitor-induced inflammatory arthritis is underappreciated and may be clinically severe, rapidly destructive, disabling, and affect a patient's…

Do NSAIDs Increase the Risk of Heart Attacks?

Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most commonly prescribed class of medicines used around the world, and are widely used by individuals with arthritis, and back pain.  Starting with the development of aspirin from the active agent found in willow bark (salicylic acid) NSAIDs have offered humans the ability to…

NOR-SWITCH Study Validates Biosimilar Use in Rheumatoid Arthritis

Results of the NOR-SWITCH study – a clinical trial performed in Norway was designed to assess the effectiveness and safety of transitioning from the originator medication Remicade (infliximab) to the less expensive biosimilar medication (Remsima/Inflectra) in the treatment of Crohn's disease, ulcerative colitis, spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic…

The US Food and Drug Administration (FDA) has Approved Kevzara an IL-6 Inhibitor for the Treatment of Rheumatoid Arthritis

Rheumatoid arthritis (RA) affects an estimated 1.3 million adults in the United States.1 The condition can have a profound effect on many aspects of daily life, and is often poorly understood by those who do not have direct experience it. The good news is that important advances have been made…

Xeljanz Effective in Ulcerative Colitis

Xeljanz (tofacitinib) is currently approved by the U. S. Food and Drug Administration (FDA), for use in the treatment of rheumatoid arthritis.  Xeljanz is also being studied in numerous other inflammatory conditions including ankylosing spondylitis, psoriatic arthritis and ulcerative colitis (UC), a form of inflammatory bowel disease. UC is an…

Nonsteroidal Anti-inflammatory Drugs for Sciatica

Nonsteroidal anti-inflammatory drugs (NSAIDs) are aspirin-like drugs used to decrease inflammation, pain and fever.  Commonly used NSAIDs include aspirin, ibuprofen, naproxen, and celecoxib.  This class of drugs is frequently used in the treatment of a wide variety of disorders that affect the musculoskeletal system, such as osteoarthritis and rheumatoid arthritis.…
image

New Online Support Group for People Affected by Gastrointestinal Conditions: IBS, Crohn’s, UC, GERD, Cancer and More

Are you suffering from a gastrointestinal (GI) tract condition? You are not alone! TheGIConnection is now available for patients, caregivers, and health consumers as an up to date online information resource and support group. Click on one of the links below to get informed and start connecting! Information: The Esophagus…

Sign up for TheRAConnection Newsletter to receive the latest news, useful tips, and feature articles.

Click here to view the RAConnection past newsletters